Public Trust Manipulation Through Health Messaging

Introduction

Public trust is essential to effective healthcare and public-health governance. People rely on governments, medical professionals, pharmaceutical companies and health authorities for accurate information about diseases, medicines, vaccines and preventive measures. Health messaging includes public announcements, advertisements, medical guidance, social-media posts and official communications concerning health.

Public trust manipulation occurs when health information is deliberately distorted, selectively presented or exaggerated to influence people’s beliefs or behaviour. It may involve false claims about medicines, misleading vaccine information, exaggerated treatment benefits, concealment of risks or the use of fear to influence public decisions.

Such manipulation can cause people to reject effective treatment, use unsafe products, delay medical care or lose confidence in legitimate public-health institutions. Indian law addresses these concerns through constitutional protections, consumer law, pharmaceutical regulation and judicial oversight.

Legal Framework

Article 21 of the Constitution protects life and personal liberty and has been interpreted to include the right to health. Article 19(1)(a) protects freedom of speech and expression, including the right to receive information. However, misleading commercial health claims may be restricted to protect public health and consumers.

Important statutes include:

Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954: Restricts advertisements making prohibited claims about drugs and remedies.

Consumer Protection Act, 2019: Provides remedies against misleading advertisements and unfair trade practices.

Food Safety and Standards Act, 2006: Regulates food safety and misleading food advertisements.

Drugs and Cosmetics Act, 1940: Regulates the quality, manufacture and sale of drugs.

Health messaging should be accurate, evidence-based, understandable and transparent about uncertainty. Public authorities should distinguish established scientific findings from preliminary evidence.

Case Laws

1. Indian Medical Association v. Union of India (2024 INSC 406)

The Supreme Court considered misleading advertisements, particularly in the health and food sectors. It emphasised that the fundamental right to health includes a consumer’s right to be informed about the quality of products offered for sale.

The Court held that advertisers, advertising agencies and endorsers have responsibilities to ensure that advertisements are not misleading. It also directed that a self-declaration be submitted before advertisements are published or aired, in accordance with the applicable framework.

National Digital Library of India+1

The judgment demonstrates that health-related messaging cannot exploit public trust or consumers’ lack of medical knowledge.

2. Hamdard Dawakhana v. Union of India (1960) 2 SCR 671

The Supreme Court considered restrictions on advertisements concerning drugs and remedies. It upheld the constitutional validity of restrictions intended to prevent misleading claims about medicinal products and protect public health.

The Court recognised the danger posed by exaggerated or deceptive therapeutic claims, particularly where they encourage unsafe self-medication.

CCGDELHI

This case establishes that commercial health messaging may be regulated where it threatens public health or misleads consumers.

3. Indian Medical Association v. V.P. Shantha (1995) 6 SCC 651

The Supreme Court held that medical services provided for consideration generally fall within the consumer-protection framework. The decision strengthened accountability in healthcare services and recognised that patients require protection from deficient medical services.

The case is relevant because misleading health communication may affect a patient’s decision to seek or continue medical treatment. Healthcare providers must communicate responsibly and avoid misleading patients about treatment or services.

4. Jacob Puliyel v. Union of India (2022) 7 SCC 1

The Supreme Court considered issues concerning COVID-19 vaccine approvals, transparency and clinical-trial information. It emphasised the importance of making legally required information available to the public while protecting the privacy of trial participants.

VoxJuris+1

The case highlights the importance of transparent communication in public-health emergencies. Public confidence depends on access to relevant information about safety, regulatory decisions and scientific evidence.

How Health Messaging Manipulates Public Trust

Health messaging may manipulate public trust through:

False therapeutic claims: Promising cures without reliable scientific evidence.

Fear-based communication: Exaggerating disease risks to promote a product or influence behaviour.

Selective disclosure: Publicising favourable research findings while concealing adverse outcomes.

Misleading endorsements: Using celebrities or public figures to suggest medical effectiveness without adequate evidence.

Institutional secrecy: Withholding relevant safety information without a legitimate legal basis.

Scientific misrepresentation: Presenting preliminary or uncertain research as established medical fact.

Conclusion

Public trust manipulation through health messaging threatens patient safety, informed decision-making and the credibility of healthcare institutions. Indian law permits regulation of misleading health claims while protecting legitimate freedom of expression. The decisions in Indian Medical Association v. Union of India, Hamdard Dawakhana and Jacob Puliyel demonstrate the importance of accurate information, regulatory transparency and accountability. Health messaging should therefore be evidence-based, proportionate and transparent, ensuring that public confidence is earned through reliable communication rather than exploited through misinformation.